Biological products: Correction,

[Federal Register: September 2, 1998 (Volume 63, Number 170)]

[Proposed Rules]

[Page 46718]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr02se98-33]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 3, 5, 10, 20, 207, 310, 312, 316, 600, 601, 607, 610, 640, and 660

[Docket No. 98N-0144]

RIN 0910-AB29

Biological Products Regulated Under Section 351 of the Public Health Services Act; Implementation of Biologics License; Elimination of Establishment License and Product License; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Proposed rule; correction.

SUMMARY: The Food and Drug Administration (FDA) is correcting a proposed rule that appeared in the Federal Register of July 31, 1998 (63 FR 40858). The document proposed to amend the biologics regulations to eliminate references to establishment licenses and product licenses for all products regulated under the Publish Health Services Act. The document published with an incorrect address. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Carolyn C. Harris, Office of Policy (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-443-2994.

SUPPLEMENTARY INFORMATION: In FR Doc. 98-20427, appearing on page 40858, in the Federal Register of Friday, July 31, 1998, the following correction is made: On page 40858, in the second column, under the ``ADDRESSES'' caption, in line four, ``12420 Parklawn Dr., rm. 1-23, Rockville, MD 20857'', is corrected to read ``5600 Fishers Lane, rm. 1061, Rockville, MD 20852''.

Dated: August 26, 1998. William K. Hubbard, Associate Commissioner for Policy Coordination.

[FR Doc. 98-23586Filed9-1-98; 8:45 am]

BILLING CODE 4160-01-F